Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
申请公布号
US2003162703(A1)
申请公布日期
2003.08.28
申请号
US20020293941
申请日期
2002.11.14
申请人
NPS ALLELIX CORPORATION
发明人
DRUCKER DANIEL J.;CRIVICI ANNA E.;SUMNER SMITH MARTIN